Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01386008 · ClinicalTrials.gov registry record · NA

Evaluation of DW Silicone Hydrogel Lens Compared to DW Silicone Hydrogel Lens

A NA study, sponsored by CooperVision.

Terminated
Registry status
NA
Development phase
28
Enrollment target

NCT01386008: Clinical Trial NA study, sponsored by CooperVision.

NCT01386008 is a NA study that was terminated before completion, run by CooperVision. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01386008, a NA study, was terminated before completion, sponsored by CooperVision.

TERMINATED
Registry status
NA
Development phase
28 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the performance of the investigational CooperVision silicone hydrogel lens compared to a currently-marketed silicone hydrogel contact lens up to 30 days of daily lens wear.

Primary Outcome

Subjective responses of participants administered by questionnaire and measured on a linear scale (0-100) measured at each visit.

Interventions

  • DEVICE senfilcon A contact lens
  • DEVICE investigational enfilcon A

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2011-05
Est. Completion 2011-06
Phase NA
CooperVision

64 total trials

Why NCT01386008 stopped before completion

NCT01386008 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which senfilcon A contact lens is the first listed.

NCT01386008 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01386008 about?

NCT01386008 is a clinical study titled "Evaluation of DW Silicone Hydrogel Lens Compared to DW Silicone Hydrogel Lens". The purpose of this study is to evaluate the performance of the investigational CooperVision silicone hydrogel lens compared to a currently-marketed silicone hydrogel contact lens up to 30 days of daily lens wear.

What is the current status of trial NCT01386008?

This trial is currently terminated. It is a NA study. The enrollment target is 28 participants. The study started on 2011-05. Estimated completion is 2011-06.

What interventions are being tested in trial NCT01386008?

The interventions under investigation include: senfilcon A contact lens (DEVICE), investigational enfilcon A (DEVICE).

Who is sponsoring clinical trial NCT01386008?

This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01386008's enrollment target sits among peer trials

28 1704th of 2000 higher than 293 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03471117 · 28 participants · Phase 4

    Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients

  • NCT03523975 · 28 participants · Phase 1

    Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma

  • NCT03608631 · 28 participants · Phase 1

    iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation

  • NCT03810651 · 28 participants · Early Phase 1

    Pencil Beam Scanning in Patients With Renal Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01386008, the US trial registry maintained by the National Library of Medicine. NCT01386008 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.